ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Lilly at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
Lilly brings 8 presentations to ACR Convergence 2026 in Orlando, and exhibits at Booth 3601, 3605. Its program centres on psoriatic arthritis with obesity, including ixekizumab with tirzepatide for disease control and cardiovascular risk, and on the immunometabolic burden of obesity in knee osteoarthritis. It also covers an oral RIPK1 inhibitor in rheumatoid arthritis.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
Lilly Indianapolis, IN | |
A pharmaceutical company that discovers and develops medicines. | Booth Exhibiting at Booth 3601, 3605 Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Poster Sun Nov 8 10:30am–12:30pm Industry Sun Nov 8 1:30pm–2:15pm New Data Can Start A New Conversation Industry Sun Nov 8 5:30pm–7:30pm Beyond the Joints: A Whole-Body Approach to Psoriatic Arthritis Care Through Integrated Obesity Management Industry Mon Nov 9 5:30pm–7:30pm Beyond the Joint: The Immunometabolic Burden of Obesity in Knee OA Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm |
Find decision makers at Lilly
Tell us what you sell and we’ll find the people at Lilly most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction